about
Safety of oral direct acting antiviral regimens for chronic hepatitis C in real life conditions.[Effectiveness of second-generation direct-acting antivirals in chronic hepatitis C].[The prevalence of diagnosed and undiagnosed hepatitis C virus infection in Navarra, Spain, 2014-2016].Survival and clinical events related to end-stage liver disease associated with HCV prior to the era of all oral direct-acting antiviral treatments.Comorbidities and cardiovascular risk factors in an aged cohort of HIV-infected patients on antiretroviral treatment in a Spanish hospital in 2016.Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patientsProgress in the elimination of hepatitis C virus infection: A population-based cohort study in SpainEconomic evaluation of a population strategy for the treatment of chronic hepatitis C with direct-acting antiviralsHealth-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population
P50
Q38875903-C0280D4A-3C86-41A4-A376-85B2F763E288Q40189636-6C366E47-E539-4E45-B13E-0DA6552D6C8EQ40362649-BBF5737F-7764-4FEF-BBCA-D3BAC51A363EQ41930571-107119FE-FD78-42C3-A5E6-F4E8D0B978F8Q51766880-B8393612-C001-4B00-B38F-E0A55201107CQ57292019-8171A503-3E35-41D9-9438-BE8372B2BAC3Q60047377-50BAF03D-AD96-4935-A389-EE52BFA2F0BEQ90389629-D32B2D78-9182-46A6-81FC-73C29A9DA8FEQ91150471-7AA40700-9F6B-4DF3-8B36-2FA17308BA77
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Regina Juanbeltz
@en
Regina Juanbeltz
@nl
type
label
Regina Juanbeltz
@en
Regina Juanbeltz
@nl
prefLabel
Regina Juanbeltz
@en
Regina Juanbeltz
@nl
P31
P496
0000-0003-3772-0442